Delta opioid receptor agonist for reducing ischemic damage
CA 2297251 A1 · Owner: Schultz, Jo El · Inventors: Schultz, Jo El; Gross, Garrett
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An agent for reducing ischemic damage to an organ having a delta (.delta.) opioid receptor in a mammal and an agent for inducing cardioprotective effect in a mammal are disclosed. The agents according to the present invention comprise an agonist to the delta (.delta.) opioid receptor.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 23, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 23, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 23, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.